13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Machine Learning Analyses on Data including Essential Oil Chemical Composition and In Vitro Experimental Antibiofilm Activities against Staphylococcus Species

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Biofilm resistance to antimicrobials is a complex phenomenon, driven not only by genetic mutation induced resistance, but also by means of increased microbial cell density that supports horizontal gene transfer across cells. The prevention of biofilm formation and the treatment of existing biofilms is currently a difficult challenge; therefore, the discovery of new multi-targeted or combinatorial therapies is growing. The development of anti-biofilm agents is considered of major interest and represents a key strategy as non-biocidal molecules are highly valuable to avoid the rapid appearance of escape mutants. Among bacteria, staphylococci are predominant causes of biofilm-associated infections. Staphylococci, especially Staphylococcus aureus ( S. aureus) is an extraordinarily versatile pathogen that can survive in hostile environmental conditions, colonize mucous membranes and skin, and can cause severe, non-purulent, toxin-mediated diseases or invasive pyogenic infections in humans. Staphylococcus epidermidis ( S. epidermidis) has also emerged as an important opportunistic pathogen in infections associated with medical devices (such as urinary and intravascular catheters, orthopaedic implants, etc.), causing approximately from 30% to 43% of joint prosthesis infections. The scientific community is continuously looking for new agents endowed of anti-biofilm capabilities to fight S. aureus and S epidermidis infections. Interestingly, several reports indicated in vitro efficacy of non-biocidal essential oils (EOs) as promising treatment to reduce bacterial biofilm production and prevent the inducing of drug resistance. In this report were analyzed 89 EOs with the objective of investigating their ability to modulate bacterial biofilm production of different S. aureus and S. epidermidis strains. Results showed the assayed EOs to modulated the biofilm production with unpredictable results for each strain. In particular, many EOs acted mainly as biofilm inhibitors in the case of S. epidermidis strains, while for S. aureus strains, EOs induced either no effect or stimulate biofilm production. In order to elucidate the obtained experimental results, machine learning (ML) algorithms were applied to the EOs’ chemical compositions and the determined associated anti-biofilm potencies. Statistically robust ML models were developed, and their analysis in term of feature importance and partial dependence plots led to indicating those chemical components mainly responsible for biofilm production, inhibition or stimulation for each studied strain, respectively.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: not found
          • Article: not found

          The random subspace method for constructing decision forests

          Tin Ho (1998)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Staphylococcal biofilms.

            M. Otto (2008)
            Staphylococcus epidermidis and Staphylococcus aureus are the most frequent causes of nosocomial infections and infections on indwelling medical devices, which characteristically involve biofilms. Recent advances in staphylococcal molecular biology have provided more detailed insight into the basis of biofilm formation in these opportunistic pathogens. A series of surface proteins mediate initial attachment to host matrix proteins, which is followed by the expression of a cationic glucosamine-based exopolysaccharide that aggregates the bacterial cells. In some cases, proteins may function as alternative aggregating substances. Furthermore, surfactant peptides have now been recognized as key factors involved in generating the three-dimensional structure of a staphylococcal biofilm by cell-cell disruptive forces, which eventually may lead to the detachment of entire cell clusters. Transcriptional profiling experiments have defined the specific physiology of staphylococcal biofilms and demonstrated that biofilm resistance to antimicrobials is due to gene-regulated processes. Finally, novel animal models of staphylococcal biofilm-associated infection have given us important information on which factors define biofilm formation in vivo. These recent advances constitute an important basis for the development of anti-staphylococcal drugs and vaccines.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests

              Effective evaluations of antimicrobial susceptibility tests (ASTs) require robust study design. The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing has recognized that many published studies reporting the performance of commercial ASTs (cASTs) suffer from major design and/or analysis flaws, rendering the results difficult or impossible to interpret. This minireview outlines the current consensus of the Methods Development and Standardization Working Group of the CLSI Subcommittee on Antimicrobial Susceptibility Testing regarding best practices for systematic evaluation of the performance of an AST, including the analysis and presentation of essential data intended for publication.
                Bookmark

                Author and article information

                Journal
                Molecules
                Molecules
                molecules
                Molecules
                MDPI
                1420-3049
                03 March 2019
                March 2019
                : 24
                : 5
                : 890
                Affiliations
                [1 ]Rome Center for Molecular Design, Department of Drug Chemistry and Technology, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy; alexandros.patsilinakos@ 123456uniroma1.it
                [2 ]Alchemical Dynamics s.r.l., 00125 Rome, Italy; manuela.sabatino@ 123456uniroma1.it
                [3 ]Department of Public Health and Infectious Diseases, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy; marco.artini@ 123456uniroma1.it (M.A.); rosanna.papa@ 123456uniroma1.it (R.P.); gianluca.vrenna@ 123456uniroma1.it (G.V.)
                [4 ]Faculty of Natural Sciences and Mathematics, University of Montenegro, 81000 Podgorica, Montenegro; mijat.bozovic@ 123456uniroma1.it
                [5 ]Department of Drug Chemistry and Technology, Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy; stefania.garzoli@ 123456uniroma1.it
                [6 ]Master Course in Cosmetic Sciences, Department of Life Sciences and Biotechnology, University of Ferrara, 44100 Ferrara, Italy; raissa.buzzi@ 123456unife.it
                Author notes
                [* ]Correspondence: smanfred@ 123456unife.it (S.M.); laura.selan@ 123456uniroma1.it (L.S.); rino.ragno@ 123456uniroma1.it (R.R.); Tel.: +39-0532-455294 (S.M.); +39-6-4969-4298 (L.S.); +39-6-4991-3937 (R.R.); Fax: +39-0532-455294 (S.M.); +39-6-4969-4298 (L.S.); +39-6-4991-3627 (R.R.)
                [†]

                These authors contributed equally to this work.

                Author information
                https://orcid.org/0000-0001-5961-3328
                https://orcid.org/0000-0001-6718-8800
                https://orcid.org/0000-0001-8535-0533
                https://orcid.org/0000-0001-5399-975X
                Article
                molecules-24-00890
                10.3390/molecules24050890
                6429525
                30832446
                96a26ba2-65b2-46d6-ac4a-74cd989a63bd
                © 2019 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 10 February 2019
                : 26 February 2019
                Categories
                Article

                biofilm,staphylococcus species,essential oil,machine learning,antimicrobial

                Comments

                Comment on this article